Trachoma prevalence after discontinuation of mass azithromycin distribution
<p><strong>Background</strong> As the World Health Organization seeks to eliminate trachoma by 2020, countries are beginning to control the transmission of trachomatous inflammation–follicular (TF) and discontinue mass drug administration (MDA) with oral azithromycin. We evaluated...
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|